APO Research
Talk to an analyst

APO RESEARCH · REPORT

Integrated Multi-Omics Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Integrated Multi-Omics Services Market Outlook and Growth Opportunities 2026

1 May 2026194 pages

Choose your research edition.

Industry ResearchIntegrated Multi-Omics Services Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Integrated Multi-Omics Services Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Integrated Multi-Omics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Integrated Multi-Omics Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Integrated Multi-Omics Services Market Analysis and Forecast 2026-2032226 pages · $4,950 USD

Market perspective

The global Integrated Multi-Omics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Integrated Multi-Omics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Integrated Multi-Omics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Integrated Multi-Omics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Integrated Multi-Omics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Integrated Multi-Omics Services market include Azenta Life Sciences, Eurofins, Source BioScience, Psomagen, Tempus, Evotec, Crown Bioscience, Sapient and Bruker Spatial Biology CRO Services, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Integrated Multi-Omics Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Integrated Multi-Omics Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Integrated Multi-Omics Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Integrated Multi-Omics Services market.

Integrated Multi-Omics Services Segment by Company

Azenta Life Sciences

Eurofins

Source BioScience

Psomagen

Tempus

Evotec

Crown Bioscience

Sapient

Bruker Spatial Biology CRO Services

Advanced Cell Diagnostics (ACD)

Panome Bio

RayBiotech

Metware Biotechnology

HaploX

Creative Proteomics

CD Genomics

Omics Empower

Cmbio

Dalton Bioanalytics

General Metabolics

Signios Bio

Source Genomics

Genechem

BGI Genomics

OE Biotech

BMKGENE

Majorbio

Wayen Biotechnologies

Integrated Multi-Omics Services Segment by Type

Dual-Omics Integration Services

Triple-Omics Integration Services

Quadruple & Above Multi-Omics Integration Services

Integrated Multi-Omics Services Segment by Application

Disease Research

Precision Medicine

Crop Breeding

Environmental Microbial Monitoring

Others

Integrated Multi-Omics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Integrated Multi-Omics Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Integrated Multi-Omics Services key companies, revenue, market share, and recent developments.

3. To split the Integrated Multi-Omics Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Integrated Multi-Omics Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Integrated Multi-Omics Services significant trends, drivers, influence factors in global and regions.

6. To analyze Integrated Multi-Omics Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Integrated Multi-Omics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Integrated Multi-Omics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Integrated Multi-Omics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Integrated Multi-Omics Services industry.

Chapter 3: Detailed analysis of Integrated Multi-Omics Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Integrated Multi-Omics Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Integrated Multi-Omics Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Integrated Multi-Omics Services Industry Trends Table 2. Integrated Multi-Omics Services Industry Drivers Table 3. Integrated Multi-Omics Services Industry Opportunities and Challenges Table 4. Integrated Multi-Omics Services Industry Restraints Table 5. Global Integrated Multi-Omics Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Integrated Multi-Omics Services Revenue Share by Company (2021-2026) Table 7. Global Integrated Multi-Omics Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Integrated Multi-Omics Services Key Company Manufacturing Base & Headquarters Table 9. Global Integrated Multi-Omics Services Company, Product Type & Application Table 10. Global Integrated Multi-Omics Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Integrated Multi-Omics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Dual-Omics Integration Services Table 15. Significant Companies of Triple-Omics Integration Services Table 16. Significant Companies of Quadruple & Above Multi-Omics Integration Services Table 17. Global Integrated Multi-Omics Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Integrated Multi-Omics Services Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Integrated Multi-Omics Services Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Integrated Multi-Omics Services Sales Value Share by Type (2021-2026) Table 21. Global Integrated Multi-Omics Services Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Disease Research Table 23. Significant Companies of Precision Medicine Table 24. Significant Companies of Crop Breeding Table 25. Significant Companies of Environmental Microbial Monitoring Table 26. Significant Companies of Others Table 27. Global Integrated Multi-Omics Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Integrated Multi-Omics Services Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Integrated Multi-Omics Services Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Integrated Multi-Omics Services Sales Value Share by Application (2021-2026) Table 31. Global Integrated Multi-Omics Services Sales Value Share by Application (2027-2032) Table 32. Global Integrated Multi-Omics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Integrated Multi-Omics Services Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Integrated Multi-Omics Services Sales Value Share by Region (2021-2026) Table 35. Global Integrated Multi-Omics Services Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Integrated Multi-Omics Services Sales Value Share by Region (2027-2032) Table 37. Global Integrated Multi-Omics Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Integrated Multi-Omics Services Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Integrated Multi-Omics Services Sales Value Market Share by Country (2021-2026) Table 40. Global Integrated Multi-Omics Services Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Integrated Multi-Omics Services Sales Value Market Share by Country (2027-2032) Table 42. Azenta Life Sciences Company Information Table 43. Azenta Life Sciences Business Overview Table 44. Azenta Life Sciences Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio Table 46. Azenta Life Sciences Recent Development Table 47. Eurofins Company Information Table 48. Eurofins Business Overview Table 49. Eurofins Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Eurofins Integrated Multi-Omics Services Product Portfolio Table 51. Eurofins Recent Development Table 52. Source BioScience Company Information Table 53. Source BioScience Business Overview Table 54. Source BioScience Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Source BioScience Integrated Multi-Omics Services Product Portfolio Table 56. Source BioScience Recent Development Table 57. Psomagen Company Information Table 58. Psomagen Business Overview Table 59. Psomagen Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Psomagen Integrated Multi-Omics Services Product Portfolio Table 61. Psomagen Recent Development Table 62. Tempus Company Information Table 63. Tempus Business Overview Table 64. Tempus Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Tempus Integrated Multi-Omics Services Product Portfolio Table 66. Tempus Recent Development Table 67. Evotec Company Information Table 68. Evotec Business Overview Table 69. Evotec Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Evotec Integrated Multi-Omics Services Product Portfolio Table 71. Evotec Recent Development Table 72. Crown Bioscience Company Information Table 73. Crown Bioscience Business Overview Table 74. Crown Bioscience Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Crown Bioscience Integrated Multi-Omics Services Product Portfolio Table 76. Crown Bioscience Recent Development Table 77. Sapient Company Information Table 78. Sapient Business Overview Table 79. Sapient Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sapient Integrated Multi-Omics Services Product Portfolio Table 81. Sapient Recent Development Table 82. Bruker Spatial Biology CRO Services Company Information Table 83. Bruker Spatial Biology CRO Services Business Overview Table 84. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio Table 86. Bruker Spatial Biology CRO Services Recent Development Table 87. Advanced Cell Diagnostics (ACD) Company Information Table 88. Advanced Cell Diagnostics (ACD) Business Overview Table 89. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio Table 91. Advanced Cell Diagnostics (ACD) Recent Development Table 92. Panome Bio Company Information Table 93. Panome Bio Business Overview Table 94. Panome Bio Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Panome Bio Integrated Multi-Omics Services Product Portfolio Table 96. Panome Bio Recent Development Table 97. RayBiotech Company Information Table 98. RayBiotech Business Overview Table 99. RayBiotech Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. RayBiotech Integrated Multi-Omics Services Product Portfolio Table 101. RayBiotech Recent Development Table 102. Metware Biotechnology Company Information Table 103. Metware Biotechnology Business Overview Table 104. Metware Biotechnology Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Metware Biotechnology Integrated Multi-Omics Services Product Portfolio Table 106. Metware Biotechnology Recent Development Table 107. HaploX Company Information Table 108. HaploX Business Overview Table 109. HaploX Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. HaploX Integrated Multi-Omics Services Product Portfolio Table 111. HaploX Recent Development Table 112. Creative Proteomics Company Information Table 113. Creative Proteomics Business Overview Table 114. Creative Proteomics Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Creative Proteomics Integrated Multi-Omics Services Product Portfolio Table 116. Creative Proteomics Recent Development Table 117. CD Genomics Company Information Table 118. CD Genomics Business Overview Table 119. CD Genomics Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. CD Genomics Integrated Multi-Omics Services Product Portfolio Table 121. CD Genomics Recent Development Table 122. Omics Empower Company Information Table 123. Omics Empower Business Overview Table 124. Omics Empower Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Omics Empower Integrated Multi-Omics Services Product Portfolio Table 126. Omics Empower Recent Development Table 127. Cmbio Company Information Table 128. Cmbio Business Overview Table 129. Cmbio Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Cmbio Integrated Multi-Omics Services Product Portfolio Table 131. Cmbio Recent Development Table 132. Dalton Bioanalytics Company Information Table 133. Dalton Bioanalytics Business Overview Table 134. Dalton Bioanalytics Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio Table 136. Dalton Bioanalytics Recent Development Table 137. General Metabolics Company Information Table 138. General Metabolics Business Overview Table 139. General Metabolics Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. General Metabolics Integrated Multi-Omics Services Product Portfolio Table 141. General Metabolics Recent Development Table 142. Signios Bio Company Information Table 143. Signios Bio Business Overview Table 144. Signios Bio Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Signios Bio Integrated Multi-Omics Services Product Portfolio Table 146. Signios Bio Recent Development Table 147. Source Genomics Company Information Table 148. Source Genomics Business Overview Table 149. Source Genomics Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Source Genomics Integrated Multi-Omics Services Product Portfolio Table 151. Source Genomics Recent Development Table 152. Genechem Company Information Table 153. Genechem Business Overview Table 154. Genechem Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Genechem Integrated Multi-Omics Services Product Portfolio Table 156. Genechem Recent Development Table 157. BGI Genomics Company Information Table 158. BGI Genomics Business Overview Table 159. BGI Genomics Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. BGI Genomics Integrated Multi-Omics Services Product Portfolio Table 161. BGI Genomics Recent Development Table 162. OE Biotech Company Information Table 163. OE Biotech Business Overview Table 164. OE Biotech Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. OE Biotech Integrated Multi-Omics Services Product Portfolio Table 166. OE Biotech Recent Development Table 167. BMKGENE Company Information Table 168. BMKGENE Business Overview Table 169. BMKGENE Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 170. BMKGENE Integrated Multi-Omics Services Product Portfolio Table 171. BMKGENE Recent Development Table 172. Majorbio Company Information Table 173. Majorbio Business Overview Table 174. Majorbio Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 175. Majorbio Integrated Multi-Omics Services Product Portfolio Table 176. Majorbio Recent Development Table 177. Wayen Biotechnologies Company Information Table 178. Wayen Biotechnologies Business Overview Table 179. Wayen Biotechnologies Integrated Multi-Omics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 180. Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio Table 181. Wayen Biotechnologies Recent Development Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Integrated Multi-Omics Services Product Image Figure 2. Global Integrated Multi-Omics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Integrated Multi-Omics Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Integrated Multi-Omics Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Dual-Omics Integration Services Image Figure 8. Triple-Omics Integration Services Image Figure 9. Quadruple & Above Multi-Omics Integration Services Image Figure 10. Global Integrated Multi-Omics Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Integrated Multi-Omics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Integrated Multi-Omics Services Sales Value Share by Type (2021-2032) Figure 13. Disease Research Image Figure 14. Precision Medicine Image Figure 15. Crop Breeding Image Figure 16. Environmental Microbial Monitoring Image Figure 17. Others Image Figure 18. Global Integrated Multi-Omics Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Integrated Multi-Omics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Integrated Multi-Omics Services Sales Value Share by Application (2021-2032) Figure 21. Global Integrated Multi-Omics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Integrated Multi-Omics Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Integrated Multi-Omics Services Sales Value (2021-2032) & (US$ Million) Figure 24. North America Integrated Multi-Omics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Integrated Multi-Omics Services Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Integrated Multi-Omics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Integrated Multi-Omics Services Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Integrated Multi-Omics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Integrated Multi-Omics Services Sales Value (2021-2032) & (US$ Million) Figure 30. South America Integrated Multi-Omics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Integrated Multi-Omics Services Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Integrated Multi-Omics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Dual-Omics Integration Services
  • Triple-Omics Integration Services
  • Quadruple & Above Multi-Omics Integration Services
Applications
  • Disease Research
  • Precision Medicine
  • Crop Breeding
  • Environmental Microbial Monitoring
  • Others
Companies covered
  • Azenta Life Sciences
  • Eurofins
  • Source BioScience
  • Psomagen
  • Tempus
  • Evotec
  • Crown Bioscience
  • Sapient
  • Bruker Spatial Biology CRO Services
  • Advanced Cell Diagnostics (ACD)
  • Panome Bio
  • RayBiotech
  • Metware Biotechnology
  • HaploX
  • Creative Proteomics
  • CD Genomics
  • Omics Empower
  • Cmbio
  • Dalton Bioanalytics
  • General Metabolics
  • Signios Bio
  • Source Genomics
  • Genechem
  • BGI Genomics
  • OE Biotech
  • BMKGENE
  • Majorbio
  • Wayen Biotechnologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Integrated Multi-Omics Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Integrated Multi-Omics Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Integrated Multi-Omics Services Market Dynamics
  1. 2.1 Integrated Multi-Omics Services Industry Trends
  2. 2.2 Integrated Multi-Omics Services Industry Drivers
  3. 2.3 Integrated Multi-Omics Services Industry Opportunities and Challenges
  4. 2.4 Integrated Multi-Omics Services Industry Restraints
3 Integrated Multi-Omics Services Market by Company
  1. 3.1 Global Integrated Multi-Omics Services Company Revenue Ranking in 2025
  2. 3.2 Global Integrated Multi-Omics Services Revenue by Company (2021-2026)
  3. 3.3 Global Integrated Multi-Omics Services Company Ranking (2024-2026)
  4. 3.4 Global Integrated Multi-Omics Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Integrated Multi-Omics Services Company Product Type and Application
  6. 3.6 Global Integrated Multi-Omics Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Integrated Multi-Omics Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Integrated Multi-Omics Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Integrated Multi-Omics Services Market by Type
  1. 4.1 Integrated Multi-Omics Services Type Introduction
  2. 4.1.1 Dual-Omics Integration Services
  3. 4.1.2 Triple-Omics Integration Services
  4. 4.1.3 Quadruple & Above Multi-Omics Integration Services
  5. 4.2 Global Integrated Multi-Omics Services Sales Value by Type
  6. 4.2.1 Global Integrated Multi-Omics Services Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Integrated Multi-Omics Services Sales Value by Type (2021-2032)
  8. 4.2.3 Global Integrated Multi-Omics Services Sales Value Share by Type (2021-2032)
5 Integrated Multi-Omics Services Market by Application
  1. 5.1 Integrated Multi-Omics Services Application Introduction
  2. 5.1.1 Disease Research
  3. 5.1.2 Precision Medicine
  4. 5.1.3 Crop Breeding
  5. 5.1.4 Environmental Microbial Monitoring
  6. 5.1.5 Others
  7. 5.2 Global Integrated Multi-Omics Services Sales Value by Application
  8. 5.2.1 Global Integrated Multi-Omics Services Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Integrated Multi-Omics Services Sales Value by Application (2021-2032)
  10. 5.2.3 Global Integrated Multi-Omics Services Sales Value Share by Application (2021-2032)
6 Integrated Multi-Omics Services Regional Value Analysis
  1. 6.1 Global Integrated Multi-Omics Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Integrated Multi-Omics Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Integrated Multi-Omics Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Integrated Multi-Omics Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Integrated Multi-Omics Services Sales Value (2021-2032)
  7. 6.3.2 North America Integrated Multi-Omics Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Integrated Multi-Omics Services Sales Value (2021-2032)
  10. 6.4.2 Europe Integrated Multi-Omics Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Integrated Multi-Omics Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Integrated Multi-Omics Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Integrated Multi-Omics Services Sales Value (2021-2032)
  16. 6.6.2 South America Integrated Multi-Omics Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Integrated Multi-Omics Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Integrated Multi-Omics Services Sales Value Share by Country, 2025 VS 2032
7 Integrated Multi-Omics Services Country-level Value Analysis
  1. 7.1 Global Integrated Multi-Omics Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Integrated Multi-Omics Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Integrated Multi-Omics Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Integrated Multi-Omics Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Integrated Multi-Omics Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Integrated Multi-Omics Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Integrated Multi-Omics Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Azenta Life Sciences
  2. 8.1.1 Azenta Life Sciences Company Information
  3. 8.1.2 Azenta Life Sciences Business Overview
  4. 8.1.3 Azenta Life Sciences Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Azenta Life Sciences Integrated Multi-Omics Services Product Portfolio
  6. 8.1.5 Azenta Life Sciences Recent Developments
  7. 8.2 Eurofins
  8. 8.2.1 Eurofins Company Information
  9. 8.2.2 Eurofins Business Overview
  10. 8.2.3 Eurofins Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Integrated Multi-Omics Services Product Portfolio
  12. 8.2.5 Eurofins Recent Developments
  13. 8.3 Source BioScience
  14. 8.3.1 Source BioScience Company Information
  15. 8.3.2 Source BioScience Business Overview
  16. 8.3.3 Source BioScience Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Source BioScience Integrated Multi-Omics Services Product Portfolio
  18. 8.3.5 Source BioScience Recent Developments
  19. 8.4 Psomagen
  20. 8.4.1 Psomagen Company Information
  21. 8.4.2 Psomagen Business Overview
  22. 8.4.3 Psomagen Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Psomagen Integrated Multi-Omics Services Product Portfolio
  24. 8.4.5 Psomagen Recent Developments
  25. 8.5 Tempus
  26. 8.5.1 Tempus Company Information
  27. 8.5.2 Tempus Business Overview
  28. 8.5.3 Tempus Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Tempus Integrated Multi-Omics Services Product Portfolio
  30. 8.5.5 Tempus Recent Developments
  31. 8.6 Evotec
  32. 8.6.1 Evotec Company Information
  33. 8.6.2 Evotec Business Overview
  34. 8.6.3 Evotec Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Evotec Integrated Multi-Omics Services Product Portfolio
  36. 8.6.5 Evotec Recent Developments
  37. 8.7 Crown Bioscience
  38. 8.7.1 Crown Bioscience Company Information
  39. 8.7.2 Crown Bioscience Business Overview
  40. 8.7.3 Crown Bioscience Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Crown Bioscience Integrated Multi-Omics Services Product Portfolio
  42. 8.7.5 Crown Bioscience Recent Developments
  43. 8.8 Sapient
  44. 8.8.1 Sapient Company Information
  45. 8.8.2 Sapient Business Overview
  46. 8.8.3 Sapient Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sapient Integrated Multi-Omics Services Product Portfolio
  48. 8.8.5 Sapient Recent Developments
  49. 8.9 Bruker Spatial Biology CRO Services
  50. 8.9.1 Bruker Spatial Biology CRO Services Company Information
  51. 8.9.2 Bruker Spatial Biology CRO Services Business Overview
  52. 8.9.3 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bruker Spatial Biology CRO Services Integrated Multi-Omics Services Product Portfolio
  54. 8.9.5 Bruker Spatial Biology CRO Services Recent Developments
  55. 8.10 Advanced Cell Diagnostics (ACD)
  56. 8.10.1 Advanced Cell Diagnostics (ACD) Company Information
  57. 8.10.2 Advanced Cell Diagnostics (ACD) Business Overview
  58. 8.10.3 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Advanced Cell Diagnostics (ACD) Integrated Multi-Omics Services Product Portfolio
  60. 8.10.5 Advanced Cell Diagnostics (ACD) Recent Developments
  61. 8.11 Panome Bio
  62. 8.11.1 Panome Bio Company Information
  63. 8.11.2 Panome Bio Business Overview
  64. 8.11.3 Panome Bio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Panome Bio Integrated Multi-Omics Services Product Portfolio
  66. 8.11.5 Panome Bio Recent Developments
  67. 8.12 RayBiotech
  68. 8.12.1 RayBiotech Company Information
  69. 8.12.2 RayBiotech Business Overview
  70. 8.12.3 RayBiotech Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 RayBiotech Integrated Multi-Omics Services Product Portfolio
  72. 8.12.5 RayBiotech Recent Developments
  73. 8.13 Metware Biotechnology
  74. 8.13.1 Metware Biotechnology Company Information
  75. 8.13.2 Metware Biotechnology Business Overview
  76. 8.13.3 Metware Biotechnology Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Metware Biotechnology Integrated Multi-Omics Services Product Portfolio
  78. 8.13.5 Metware Biotechnology Recent Developments
  79. 8.14 HaploX
  80. 8.14.1 HaploX Company Information
  81. 8.14.2 HaploX Business Overview
  82. 8.14.3 HaploX Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 HaploX Integrated Multi-Omics Services Product Portfolio
  84. 8.14.5 HaploX Recent Developments
  85. 8.15 Creative Proteomics
  86. 8.15.1 Creative Proteomics Company Information
  87. 8.15.2 Creative Proteomics Business Overview
  88. 8.15.3 Creative Proteomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Creative Proteomics Integrated Multi-Omics Services Product Portfolio
  90. 8.15.5 Creative Proteomics Recent Developments
  91. 8.16 CD Genomics
  92. 8.16.1 CD Genomics Company Information
  93. 8.16.2 CD Genomics Business Overview
  94. 8.16.3 CD Genomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CD Genomics Integrated Multi-Omics Services Product Portfolio
  96. 8.16.5 CD Genomics Recent Developments
  97. 8.17 Omics Empower
  98. 8.17.1 Omics Empower Company Information
  99. 8.17.2 Omics Empower Business Overview
  100. 8.17.3 Omics Empower Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Omics Empower Integrated Multi-Omics Services Product Portfolio
  102. 8.17.5 Omics Empower Recent Developments
  103. 8.18 Cmbio
  104. 8.18.1 Cmbio Company Information
  105. 8.18.2 Cmbio Business Overview
  106. 8.18.3 Cmbio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cmbio Integrated Multi-Omics Services Product Portfolio
  108. 8.18.5 Cmbio Recent Developments
  109. 8.19 Dalton Bioanalytics
  110. 8.19.1 Dalton Bioanalytics Company Information
  111. 8.19.2 Dalton Bioanalytics Business Overview
  112. 8.19.3 Dalton Bioanalytics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Dalton Bioanalytics Integrated Multi-Omics Services Product Portfolio
  114. 8.19.5 Dalton Bioanalytics Recent Developments
  115. 8.20 General Metabolics
  116. 8.20.1 General Metabolics Company Information
  117. 8.20.2 General Metabolics Business Overview
  118. 8.20.3 General Metabolics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 General Metabolics Integrated Multi-Omics Services Product Portfolio
  120. 8.20.5 General Metabolics Recent Developments
  121. 8.21 Signios Bio
  122. 8.21.1 Signios Bio Company Information
  123. 8.21.2 Signios Bio Business Overview
  124. 8.21.3 Signios Bio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Signios Bio Integrated Multi-Omics Services Product Portfolio
  126. 8.21.5 Signios Bio Recent Developments
  127. 8.22 Source Genomics
  128. 8.22.1 Source Genomics Company Information
  129. 8.22.2 Source Genomics Business Overview
  130. 8.22.3 Source Genomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Source Genomics Integrated Multi-Omics Services Product Portfolio
  132. 8.22.5 Source Genomics Recent Developments
  133. 8.23 Genechem
  134. 8.23.1 Genechem Company Information
  135. 8.23.2 Genechem Business Overview
  136. 8.23.3 Genechem Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Genechem Integrated Multi-Omics Services Product Portfolio
  138. 8.23.5 Genechem Recent Developments
  139. 8.24 BGI Genomics
  140. 8.24.1 BGI Genomics Company Information
  141. 8.24.2 BGI Genomics Business Overview
  142. 8.24.3 BGI Genomics Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  143. 8.24.4 BGI Genomics Integrated Multi-Omics Services Product Portfolio
  144. 8.24.5 BGI Genomics Recent Developments
  145. 8.25 OE Biotech
  146. 8.25.1 OE Biotech Company Information
  147. 8.25.2 OE Biotech Business Overview
  148. 8.25.3 OE Biotech Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  149. 8.25.4 OE Biotech Integrated Multi-Omics Services Product Portfolio
  150. 8.25.5 OE Biotech Recent Developments
  151. 8.26 BMKGENE
  152. 8.26.1 BMKGENE Company Information
  153. 8.26.2 BMKGENE Business Overview
  154. 8.26.3 BMKGENE Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  155. 8.26.4 BMKGENE Integrated Multi-Omics Services Product Portfolio
  156. 8.26.5 BMKGENE Recent Developments
  157. 8.27 Majorbio
  158. 8.27.1 Majorbio Company Information
  159. 8.27.2 Majorbio Business Overview
  160. 8.27.3 Majorbio Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Majorbio Integrated Multi-Omics Services Product Portfolio
  162. 8.27.5 Majorbio Recent Developments
  163. 8.28 Wayen Biotechnologies
  164. 8.28.1 Wayen Biotechnologies Company Information
  165. 8.28.2 Wayen Biotechnologies Business Overview
  166. 8.28.3 Wayen Biotechnologies Integrated Multi-Omics Services Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Wayen Biotechnologies Integrated Multi-Omics Services Product Portfolio
  168. 8.28.5 Wayen Biotechnologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst